Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Lung cancer patients undergoing upfront surgery, highly benefit from a systematic lymph node dissection in the mediastinum and in the surgical specimens. The latter is performed by the pathologist. Developing a standardized technique to dissect the lobectomy specimen has the potential of maximizing the retrieval of all N1 stations lymph nodes. The investigators believe that the adoption of such technique will improve lung cancer staging and identify a higher number of patients that qualify for adjuvant therapies.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Subjects with a lung nodule or mass who are eligible to undergo a lobectomy.
• Subject without any metastasis present.
• Subjects who have peripheral lung nodule location
• Subjects must be 18 years of age or older.
Locations
United States
Massachusetts
Brigham and Womens Hospital
RECRUITING
Boston
Contact Information
Primary
Paula Ugalde Figueroa, M.D.
pugaldefigueroa@bwh.harvard.edu
(617) 732-7696
Time Frame
Start Date: 2024-07-26
Estimated Completion Date: 2027-12
Participants
Target number of participants: 160
Treatments
Experimental: 1. Interventional group
subjects who are being consented to this study and undergoing lymph node dissection as outlined in this protocol
No_intervention: Concurrent non-interventional group
Other: Retrospective cohort from 2021-2020
Related Therapeutic Areas
Sponsors
Leads: Brigham and Women's Hospital